For humans and animal models alike there is general agreement that the central nervous system processing of gastrointestinal (GI) signals arising from ingested food provides the principal determinant of the size of meals and their frequency. Despite this, relatively few studies are aimed at delineating the brain circuits, neurochemical pathways and intracellular signals that mediate GI-stimulation-induced intake inhibition. Two additional motivations to pursue these circuits and signals have recently arisen. First, the success of gastric-bypass surgery in obesity treatment is highlighting roles for GI signals such as glucagon-like peptide-1 (GLP-1) in intake and energy balance control. Second, accumulating data suggest that the intakereducing effects of leptin may be mediated through an amplification of the intake-inhibitory effects of GI signals. Experiments reviewed show that: (1) the intake-suppressive effects of a peripherally administered GLP-1 receptor agonist is mediated by caudal brainstem neurons and that forebrain-hypothalamic neural processing is not necessary for this effect; (2) a population of medial nucleus tractus solitarius (NTS) neurons that are responsive to gastric distention is also driven by leptin; (3) caudal brainstem-targeted leptin amplifies the food-intake-inhibitory effects of gastric distention and intestinal nutrient stimulation; (4) adenosine monophosphate-activated protein kinase (AMPK) activity in NTS-enriched brain lysates is elevated by food deprivation and reduced by refeeding and (5) the intake-suppressive effect of hindbrain-directed leptin is reversed by elevating hindbrain AMPK activity. Overall, data support the view that the NTS and circuits within the hindbrain mediate the intake inhibition of GI signals, and that the effects of leptin on food intake result from the amplification of GI signal processing.
Introduction
The ingestion of food gives rise to mechanical and chemical stimulation of the gastrointestinal (GI) tract and, in turn, to the secretion of a variety of GI hormones. These events activate vagal afferent neurons, which project to and stimulate the central-visceral afferent pathway, which in turn includes neurons located in the medulla, pons, hypothalamus and ventral forebrain. Specific subnuclei of the nucleus tractus solitarius (NTS) are the first central neurons to process ingestion-related vagal afferent signals. Central processing of these signals is widely regarded as the primary determinant of the reduced food intake that follows meal consumption. 1 For this reason, research aimed at defining the central nervous system (CNS) circuits and neurochemical events that mediate the intake-inhibitory action of GI signals is likely to provide clues to the development of new obesity treatments. The clinical relevance of GI signals and their central processing is underscored by the success of gastric-bypass surgery in treating morbid obesity and type 2 diabetes mellitus. Analyses of large numbers of gastric-bypass cases show that on average, patients lose B35% of their pre-surgery body weight within the initial year and that 10 years post-surgery, the majority of the lost weight is not regained. ). A determination of which of these implicated structures are necessary for GLP-1R-mediated response production has not been made. Nonetheless, it is often asserted that hypothalamic/forebrain processing is critical for mediating the effects of peripheral GLP-1R stimulation as well as central activation. 11, [28] [29] [30] [31] [32] We review the results from experiments that used complete supracollicular transection of the rat brain to: (1) block the ascending projections to the hypothalamus and ventral forebrain that originate in the caudal brainstem; (2) remove descending projections from the hypothalamus and basal forebrain to hindbrain behavioral and autonomic effectors and thereby (3) eliminate forebrain-caudal brainstem communication. 33 This strategy was used to directly investigate the importance of hypothalamic/forebrain and caudal brainstem processing in the mediation of behavioral, sympathetic and parasympathetic responses generated by peripheral or central GLP-1R agonist treatment. The selective agonist to the GLP-1 receptor, Ex-4, was selected as the ligand of choice to examine GLP-1R-mediated control of food intake and gastric emptying, as this compound is used, both experimentally and clinically in the treatment of diabetes mellitus and obesity. [34] [35] [36] [37] [38] Control and chronic supracollicular decerebrate rats received Ex-4 or vehicle through IP injection or through the fourth intracerebroventricular cannula. Food intake was assessed using direct oral delivery of liquid nutrient. The intraoral intake method is required for the assessment of intake in chronic decerebrate rats and has been validated for the assessment of intake in intact rats. 39, 40 Gastric emptying was measured using dyedilution spectrophotometry. 41 Inhibition for food intake and gastric emptying in response to peripheral Ex-4 was comparable to intact control and decerebrate rats, as were the dose-response relationships, indicating the caudal brainstem is sufficient for mediating response production. 33 This result is consistent with a body of other work from our laboratory from which we conclude that in the absence of connections between forebrain and caudal brainstem neurons, integrations carried out in the isolated caudal brainstem of the chronic decerebrate rat and efferent projections from this region are, (1) sufficient for a fundamentally normal oropharyngeal organization of meal consumption and, moreover, (2) mediate the integration of food taste and GI afferent signals (for example, nutrient load, cholecystokinin treatment) that codetermine meal size control in neurologically intact rats. 43 Central delivery of Ex-4 with hindbrain-directed fourth intracerebroventricular injections produced similar intakesuppressive effects in chronic decerebrate and neurologically intact controls. These findings show that caudal brainstem processing is sufficient to mediate feeding effects triggered by stimulation of hindbrain GLP-1R, and that hypothalamic/ forebrain processing is not necessary for this centrally evoked response. At the same time, however, it is known that intake inhibition is observed following ventral forebrain application of GLP-1R ligands. As ligands are accessible to both forebrain and hindbrain GLP-1Rs with forebrain ventricular GLP-1R agonist delivery, it is difficult to ascribe this to the CNS sites mediating this effect, but ventral forebrain parenchymal application of GLP-1R ligands does elicit behavioral responses, and this result does support a direct role for forebrain GLP-1R and forebrain neural processing in for the observed effects. 44, 45 Neither our study 33 nor the central agonist delivery studies of others 28, 44, 45 address the sites of central mediation of responses resulting from endogenous activation of central GLP-1Rs. Although the source of the proglucagon-expressing neurons is located in the NTS of the caudal brainstem, these neurons project to both hindbrain and forebrain nuclear targets. 46 Further investigations are required to determine the role of endogenous activation of caudal brainstem and ventral forebrain GLP-1R in the mediation of responses resulting from endogenous central GLP-1. For responses generated by exogenous hindbrain-directed central delivery of GLP-1R ligands, by contrast, the findings are clear; responses induced by exogenous hindbrain application of GLP-1R agonists do not require forebrain processing or caudal brainstem-forebrain communication.
33
Leptin interacts with GI signal processing
Leptin, the adipose tissue-derived hormone, is a major contributor to energy balance control, largely through its actions on CNS receptors. 47 Leptin administration reduces food intake, and despite intense research its neural basis remains unexplained. Leptin signaling in the neuropeptidecontaining neurons of the arcuate nucleus was the initial focus of the field; 48 however, the scope of more recent work has expanded to include functional assessments of leptin signaling in the ventral medial hypothalamus and the midbrain ventral tegmental area. [49] [50] [51] Our attention was drawn to leptin signaling in NTS neurons by behavioral findings that suggest leptin's effect on feeding results from amplification of the neural processing of intake-inhibitory GI signals, 52, 53 and by the electrophysiological data of Schwartz and Moran 54 that show leptin potentiation of the NTS response to gastric distention. In collaboration with Christian Bjorbaek and Lihong Huo, 53 we undertook a detailed anatomical analysis of the NTS subnuclear expression of intraperitoneal leptin-induced pSTAT3 immunoreactivity (IR) and showed that IR was limited to a portion of single subnucleus neurons of the medial NTS, specifically at the level of the area postrema. We were struck by this expression pattern, as medial NTS neurons were also known to process GI vagal afferent signals arising from ingesta interacting with the stomach and intestine, [54] [55] [56] [57] [58] [59] and set out to address whether leptin signaling (intraperitoneal leptin-induced pSTAT3-IR) and physiological levels of gastric distension-induced Fos-IR were expressed by the same NTS neurons. We found that B40% of pSTAT3-IR medial NTS neurons are also responsive to gastric distention. 53 The results of two behavioral studies are consistent with the hypothesis that hindbrain leptin signaling potentiates the intake-inhibitory effects of GI signals.
A volume of gastric distention 53 or a caloric concentration of intraduodenal intralipid (triglyceride emulsion) infusion (Hayes and Grill, unpublished) without effect on intake were combined with a behaviorally ineffective dose of fourth intracerebroventricular leptin. In the two studies, neither the leptin alone nor the GI treatment alone reduced intake. When leptin and GI treatment were combined, however, food intake was significantly suppressed. The observed food intake suppression suggests that leptin signaling directed to the caudal brainstem neurons resulted in an amplification of the intake-suppressive action of GI stimulation. These behavioral results and the expression of distention-induced Fos-IR and pSTAT3-IR in the same medial NTS neurons suggest a siteFmedial NTS neuronsFand a mechanismF potentiation of GI satiation signals by leptinFto explain the intake-reducing action of leptin. Given the growing interest in brain adenosine monophosphate-activated protein kinase (AMPK) as a cellular fuel gauge that regulates energy balance, 60, 61 as well as evidence from hypothalamic tissues that show leptin and refeeding (associated with GI stimulation) decrease the elevated AMPK activity induced by food deprivation, we have been pursuing the hypothesis that leptin and GI signals processed in NTS neurons combine to affect intracellular AMPK activity. Using western blots and activity assays we show that food deprivation elevates and refeeding reduces AMPK activity in NTS-enriched lysates. 62 Moreover, we show that the intake reduction resulting from hindbrain-directed leptin is reversed by hindbrain-directed treatment with AICA, an AMPmimicking promoter of AMPK activity. Our data are consistent with the hypothesis that the intake-inhibitory effect of leptin is mediated in part by the synergistic actions of leptin and GI vagal afferent signaling in medial NTS neurons, and that AMPK activity in these neurons may be a signal common to both effects. Overall, the data reviewed here support the view that NTS and circuits present within the hindbrain mediate the intake inhibition of GI signals such as GLP-1, and that the intakesuppressive effect of leptin results, at least in part, from the amplification of GI signal processing.
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